Catalyst Pharmaceuticals Inc (CPRX)
Debt-to-capital ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 727,632 | 660,941 | 608,655 | 561,412 | 387,881 | 348,548 | 375,294 | 333,661 | 300,421 | 270,041 | 241,092 | 220,221 | 206,831 | 198,661 | 188,944 | 178,651 | 169,598 | 156,628 | 111,201 | 99,676 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $727,632K)
= 0.00
The debt-to-capital ratio of Catalyst Pharmaceuticals Inc has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has no debt in its capital structure during the period under review. This signifies that Catalyst Pharmaceuticals Inc has been operating without relying on external borrowing to fund its operations, acquisitions, or expansions. A low or zero debt-to-capital ratio can be viewed positively by investors and creditors as it implies lower financial risk and potential for better financial stability. However, it is also essential to consider other financial ratios and factors to gain a holistic understanding of the company's financial health and performance.
Peer comparison
Dec 31, 2024